Biotech
Summit's Lung Cancer Drug Progress
Summit's new drug for lung cancer demonstrated promising results in recent assessments. This development is part of ongoing biotech advancements in oncology. It was reported alongside other health innovations.
Beyond Meat investor eyes ETHZilla after stock rally
Dimitri Semenikhin, the retail trader who sparked the recent Beyond Meat stock rally, has announced a new investment in ETHZilla Corporation. The company, formerly a biotech firm known as 180 Life Sciences, recently pivoted to a digital asset treasury focused on ethereum. ETHZilla's shares surged following Semenikhin's disclosure, amid a broader trend of companies adopting crypto treasuries in 2025.
Cellular Treatment Outperforms Chemo in Cancer Models
AI द्वारा रिपोर्ट किया गया तथ्य-जाँच किया गया
A new treatment tested in brain organoids with glioblastoma outperformed chemotherapy and dramatically reduced tumors in mice. Human trials are upcoming. The approach also explores stem cell stimulation and aging cell rejuvenation for broader immunotherapy applications.
Stem Cell EVs Aid Tissue Repair
AI द्वारा रिपोर्ट किया गया तथ्य-जाँच किया गया
StemDAO is developing therapies using extracellular vesicles from stem cells to address soft tissue injuries, cognitive decline, and aging. Clinical data shows benefits in cognition, skin health, and inflammation reduction. This approach triggers natural regeneration without surgery.
Vaccine Therapy Progress for Brain Tumors
AI द्वारा रिपोर्ट किया गया तथ्य-जाँच किया गया
Vaccine therapy for malignant glioma is advancing, with calls for expedited approvals to treat this aggressive brain cancer. The approach has potential to save lives and is part of efforts for rare disease treatments. Early results indicate effectiveness without traditional chemo or radiation.